Proteinuric Nephropathy in Acquired and Congenital Generalized Lipodystrophy: Baseline Characteristics and Course during Recombinant Leptin Therapy

Effects of Recombinant Leptin Therapy in a Child with Congenital Leptin Deficiency

Farooqi, I. S., Jebb, S. A., Langmack, G., Lawrence, E., Cheetham, C. H., Prentice, A. M., Hughes, I. A., McCamish, M. A., & O'Rahilly, S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909163411204 · Cited by 1,998

Recombinant Leptin for Weight Loss in Obese and Lean Adults: A Randomized, Controlled, Dose-Escalation Trial

Heymsfield, S. B., Greenberg, A. S., Fujioka, K., Dixon, R. M., Kushner, R., Hunt, T., Lubina, J. A., Patane, J., Self, B., Hunt, P., et al. (1999) · JAMA · doi:10.1001/jama.282.16.1568 · Cited by 1,422

Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency

Farooqi, I. S., Matarese, G., Lord, G. M., Keogh, J. M., Lawrence, E., Agwu, C., Sanna, V., Jebb, S. A., Perna, F., Fontana, S., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15693 · Cited by 1,374

Leptin-Replacement Therapy for Lipodystrophy

Oral, E. A., Simha, V., Ruiz, E., Andewelt, A., Premkumar, A., Snell, P., Wagner, A. J., DePaoli, A. M., Reitman, M. L., Taylor, S. I., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012437 · Cited by 1,247

Update on the 1987 Task Force Report on High Blood Pressure in Children and Adlescents : A Work Group Report from the National High Blood Pressure Education Program

Lung (1996) · PEDIATRICS · Cited by 867

Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy

Petersen, K. F., Oral, E. A., Dufour, S., Befroy, D., Ariyan, C., Yu, C., Cline, G. W., DePaoli, A. M., Taylor, S. I., Gorden, P., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215001 · Cited by 800

Identification of the gene altered in Berardinelli–Seip congenital lipodystrophy on chromosome 11q13

Magré, J., Délepine, M., Khallouf, E., Gedde‐Dahl, T., Maldergem, L. V., Sobel, E. M., Papp, J. C., Meier, M., Mégarbané, A., BSCL Working Group, et al. (2001) · Nature Genetics · doi:10.1038/ng585 · Cited by 755

AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34

Agarwal, A. K., Oral, E. A., de Almeida, S., Akkoç, N., Taylor, S. I., Bowcock, A. M., Barnes, R. I., & Garg, A. (2002) · Nature Genetics · doi:10.1038/ng880 · Cited by 527

Radioimmunoassay of leptin in human plasma

Ma, Z., Gingerich, R. L., Santiago, J. V., Klein, S., Smith, C. H., & Landt, M. (1996) · Clinical Chemistry · doi:10.1093/clinchem/42.6.942 · Cited by 490

Leptin stimulates proliferation and TGF-β expression in renal glomerular endothelial cells: Potential role in glomerulosclerosis

Wolf, G., Hamann, A., Han, D. C., Helmchen, U. M., Thaiss, F., Ziyadeh, F. N., & Stahl, R. A. K. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00626.x · Cited by 391

Inflammation and the pathogenesis of diabetic nephropathy

Wada, J., & Makino, H. (2012) · Clinical Science · doi:10.1042/cs20120198 · Cited by 793

The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline

Brown, R. J., Araújo‐Vilar, D., Cheung, P. T., Dunger, D. B., Garg, A., Jack, M., Mungai, L., Oral, E. A., Patni, N., Rother, K. I., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2466 · Cited by 540

Regulation of Renal Lipid Metabolism, Lipid Accumulation, and Glomerulosclerosis in FVB db/db Mice With Type 2 Diabetes

Wang, Z., Jiang, T., Li, J., Proctor, G., McManaman, J. L., Lucia, S. M., Chua, S. C., & Levi, M. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2328 · Cited by 302

Regulation of Renal Fatty Acid and Cholesterol Metabolism, Inflammation, and Fibrosis in Akita and OVE26 Mice With Type 1 Diabetes

Proctor, G., Jiang, T., Iwahashi, M., Wang, Z., Li, J., & Levi, M. (2006) · Diabetes · doi:10.2337/db05-0603 · Cited by 303

Congenital generalized lipodystrophies—new insights into metabolic dysfunction

Patni, N., & Garg, A. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.123 · Cited by 262

Lipodystrophy: pathophysiology and advances in treatment

Fiorenza, C. G., Chou, S. H.-H., & Mantzoros, C. S. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.199 · Cited by 255

Efficacy and Safety of Leptin-Replacement Therapy and Possible Mechanisms of Leptin Actions in Patients with Generalized Lipodystrophy

Ebihara, K., Kusakabe, T., Hirata, M., Masuzaki, H., Miyanaga, F., Kobayashi, N., Tanaka, T., Chusho, H., Miyazawa, T., Hayashi, T., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1546 · Cited by 231

Long-Term Efficacy of Leptin Replacement in Patients With Generalized Lipodystrophy

Javor, E. D., Cochran, E. K., Musso, C., Young, J. R., DePaoli, A. M., & Gorden, P. (2005) · Diabetes · doi:10.2337/diabetes.54.7.1994 · Cited by 226

Nephropathy in males and females with Fabry disease: cross-sectional description of patients before treatment with enzyme replacement therapy

Ortíz, A., Oliveira, J. P., Waldek, S., Warnock, D. G., Cianciaruso, B., Wanner, C., & on behalf of the Fabry Registry (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm848 · Cited by 226

Role of leptin in blood pressure regulation and arterial hypertension

Bełtowski, J. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000222743.06584.66 · Cited by 220

Side Effects of Cytokines Approved for Therapy

Baldo, B. A. (2014) · Drug Safety · doi:10.1007/s40264-014-0226-z · Cited by 195

Partial and Generalized Lipodystrophy: Comparison of Baseline Characteristics and Response to Metreleptin

Diker‐Cohen, T., Cochran, E. K., Görden, P., & Brown, R. J. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4491 · Cited by 181

Efficacy of leptin therapy in the different forms of human lipodystrophy

Chong, A. Y., Lupsa, B. C., Cochran, E. K., & Görden, P. (2009) · Diabetologia · doi:10.1007/s00125-009-1502-9 · Cited by 175

Genetic Modulation of Senescent Phenotypes in Homo sapiens

Martin, G. M. (2005) · Cell · doi:10.1016/j.cell.2005.01.031 · Cited by 177

Saturated fatty acids induce insulin resistance in human podocytes: implications for diabetic nephropathy

Lennon, R., Pons, D., Sabin, M. A., Wei, C., Hamilton-Shield, J. P., Coward, R. J., Tavaré, J. M., Mathieson, P. W., Saleem, M. A., & Welsh, G. I. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp302 · Cited by 148

Extreme phenotypic diversity and nonpenetrance in families with the LMNA gene mutation R644C

Rankin, J., Auer‐Grumbach, M., Bagg, W., Colclough, K., Dương, N. T., Fenton‐May, J., Hattersley, A. T., Hudson, J. A., Jardine, P. E., Josifova, D. J., et al. (2008) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32331 · Cited by 109

Natural History of Congenital Generalized Lipodystrophy: A Nationwide Study From Turkey

Akıncı, B., Önay, H., Demir, T., Özen, S., Kayserili, H., Akıncı, G., Nur, B. G., Tüysüz, B., Özbek, M. N., Güngör, Â., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1005 · Cited by 99

Comparison of Efficacy and Safety of Leptin Replacement Therapy in Moderately and Severely Hypoleptinemic Patients with Familial Partial Lipodystrophy of the Dunnigan Variety

Simha, V., Subramanyam, L., Szczepaniak, L. S., Quittner, C., ADAMS-HUET, B. A., Snell, P. G., & Garg, A. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2229 · Cited by 96

Clinical Classification and Treatment of Congenital and Acquired Lipodystrophy

Chan, J. L., & Oral, E. A. (2010) · Endocrine Practice · doi:10.4158/ep09154.ra · Cited by 93

Complement Abnormalities in Acquired Lipodystrophy Revisited

Savage, D. B., Semple, R. K., Clatworthy, M. R., Lyons, P., Morgan, B. P., Cochran, E. K., Görden, P., Raymond‐Barker, P., Murgatroyd, P. R., Adams, C., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1703 · Cited by 87

Type 1 Diabetes Associated with Acquired Generalized Lipodystrophy and Insulin Resistance: The Effect of Long-Term Leptin Therapy

Park, J. Y., Chong, A. Y., Cochran, E. K., Kleiner, D. E., Haller, M. J., Schatz, D., & Görden, P. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1856 · Cited by 79

Rationale for Leptin-Replacement Therapy for Severe Lipodystrophy

Oral, E. A., & Chan, J. L. (2010) · Endocrine Practice · doi:10.4158/ep09155.ra · Cited by 77

Metreleptin for injection to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy

Meehan, C. A., Cochran, E. K., Kassai, A., Brown, R. J., & Görden, P. (2015) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2016.1096772 · Cited by 74

Leptin Replacement Therapy Modulates Circulating Lymphocyte Subsets and Cytokine Responsiveness in Severe Lipodystrophy

Oral, E. A., Javor, E. D., Ding, L., Uzel, G., Cochran, E. K., Young, J. R., DePaoli, A. M., Holland, S. M., & Görden, P. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1220 · Cited by 69

Leptin in congenital and HIV-associated lipodystrophy

Tsoukas, M. A., Farr, O. M., & Mantzoros, C. S. (2014) · Metabolism · doi:10.1016/j.metabol.2014.07.017 · Cited by 58

Spectrum of Renal Diseases Associated with Extreme Forms of Insulin Resistance

Musso, C., Javor, E. D., Cochran, E. K., Balow, J. E., & Görden, P. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01271005 · Cited by 56

Secondary Glomerular Disease

Appel, G. B., Radhakrishnan, J., & D’Agati, V. D. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-6193-9.10032-6 · Cited by 56

Lipodystrophies: adipose tissue disorders with severe metabolic implications

Cortés, V., & Fernández‐Galilea, M. (2015) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-015-0404-1 · Cited by 53

Lipodystrophy for the Diabetologist—What to Look For

Patni, N., & Garg, A. (2022) · Current Diabetes Reports · doi:10.1007/s11892-022-01485-w · Cited by 52

Diagnostic strategies and clinical management of lipodystrophy

Foss‐Freitas, M. C., Akıncı, B., Luo, Y., Stratton, A., & Oral, E. A. (2020) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2020.1735360 · Cited by 53

Adipokines in the HIV/HAART-associated lipodystrophy syndrome

Paruthi, J., Gill, N., & Mantzoros, C. S. (2013) · Metabolism · doi:10.1016/j.metabol.2013.04.014 · Cited by 46

Current Diagnosis, Treatment and Clinical Challenges in the Management of Lipodystrophy Syndromes in Children and Young People

Özen, S., Akıncı, B., & Oral, E. A. (2019) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2019.2019.0124 · Cited by 44

Update on Therapeutic Options in Lipodystrophy

Akıncı, B., Meral, R., & Oral, E. A. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1100-7 · Cited by 41

Leptin induces TNFα-dependent inflammation in acquired generalized lipodystrophy and combined Crohn’s disease

Ziegler, J., Böttcher, C., Letizia, M., Yerinde, C., Wu, H., Freise, I., Rodriguez‐Sillke, Y., Stoyanova, A. K., Kreis, M. E., Asbach, P., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13559-7 · Cited by 39

Cosegregation of Focal Segmental Glomerulosclerosis in a Family with Familial Partial Lipodystrophy due to a Mutation in LMNA

Thong, K. M., Xu, Y., Cook, J. A., Takou, A., Wagner, B. E., Kawar, B., & Ong, A. C. M. (2013) · Nephron Clinical Practice · doi:10.1159/000354716 · Cited by 38

Renal complications of lipodystrophy: A closer look at the natural history of kidney disease

Akıncı, B., Ünlü, Ş. M., Çelik, A., Şimşir, İ. Y., Şen, S., Nur, B. G., Keskin, F. E., Saydam, B. Ö., Kutbay, N. Ö., Yürekli, B. Ş., et al. (2018) · Clinical Endocrinology · doi:10.1111/cen.13732 · Cited by 36

Role of the kidney in the metabolism of apolipoprotein A-IV: influence of the type of proteinuria

Lingenhel, A., Lhotta, K., Neyer, U., Heid, I. M., Rantner, B., Kronenberg, M. F., König, P., von Eckardstein, A., Schober, M., Dieplinger, H., et al. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600178-jlr200 · Cited by 33

An overview of lipodystrophy and the role of the complement system

Corvillo, F., & Akıncı, B. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2019.05.011 · Cited by 31

Metreleptin and generalized lipodystrophy and evolving therapeutic perspectives

Tchang, B. G., Shukla, A. P., & Aronne, L. J. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1052789 · Cited by 28

Clinical features of generalized lipodystrophy in Turkey: A cohort analysis

Şimşir, İ. Y., Tüysüz, B., Özbek, M. N., Tanrıkulu, S., Güler, M. Ç., Karhan, A. N., Öngen, Y. D., Güneş, N., Soyaltın, U. E., Altay, C., et al. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15061 · Cited by 28

Adipose tissue transplantation ameliorates lipodystrophy-associated metabolic disorders in seipin-deficient mice

Wang, H., Xu, P., Li, J., Liu, X., Wu, X., Fang, X., Xie, B., Huang, X., Zhou, Z., Kayoumu, A., et al. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00180.2018 · Cited by 28

Renal injury in Seipin ‐deficient lipodystrophic mice and its reversal by adipose tissue transplantation or leptin administration alone: adipose tissue‐kidney crosstalk

Liu, X., Wu, X., Wang, H., Wang, S., Kong, W., Zhang, L., Liu, C., & Huang, W. Y. (2018) · The FASEB Journal · doi:10.1096/fj.201701427r · Cited by 27

Therapeutic use of recombinant methionyl human leptin

Vatier, C., Gautier, J., & Vigouroux, C. (2012) · Biochimie · doi:10.1016/j.biochi.2012.03.013 · Cited by 29

Lipid partitioning after uninephrectomy

Zhao, H., Sui, Y., He, L., Guan, J. Z., Xiao, S., Zhong, D., Xu, Q. R., & Zeng, S. (2011) · Acta Diabetologica · doi:10.1007/s00592-011-0286-9 · Cited by 25

A rapid action plan to improve diagnosis and management of lipodystrophy syndromes

Fourman, L. T., Lima, J. G., Simha, V., Cappa, M., Al-Yaarubi, S., Montenegro, R. M., Akıncı, B., & Santini, F. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1383318 · Cited by 24

Role of Seipin in Human Diseases and Experimental Animal Models

Li, Y., Yang, X., Peng, L., Xia, Q., Zhang, Y., Huang, W., Liu, T., & Jia, D. (2022) · Biomolecules · doi:10.3390/biom12060840 · Cited by 23

Acute leptin exposure reduces megalin expression and upregulates TGFβ1 in cultured renal proximal tubule cells

Briffa, J. F., Grinfeld, E., Mathai, M. L., Poronnik, P., McAinch, A. J., & Hryciw, D. H. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.11.024 · Cited by 24

Body Fat Distribution Contributes to Defining the Relationship between Insulin Resistance and Obesity in Human Diseases

Adeva‐Andany, M. M., Domínguez-Montero, A., Adeva-Contreras, L., Fernández‐Fernández, C., Carneiro-Freire, N., & González-Lucán, M. (2023) · Current Diabetes Reviews · doi:10.2174/1573399820666230816111624 · Cited by 25

Leptin in Relation to the Lipodystrophy-Associated Metabolic Syndrome

Mantzoros, C. S. (2012) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2012.36.3.181 · Cited by 22

The renal phenotype of allopurinol-treated HPRT-deficient mouse

Zennaro, C., Tonon, F., Zarattini, P., Clai, M., Corbelli, A., Carraro, M., Marchetti, M., Ronda, L., Paredi, G., Rastaldi, M. P., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173512 · Cited by 19

Effects of Metreleptin on Proteinuria in Patients With Lipodystrophy

Lee, H. L., Waldman, M. A., Auh, S., Balow, J. E., Cochran, E. K., Görden, P., & Brown, R. J. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00200 · Cited by 19

Leptin therapy in lipodystrophy

Savage, D. B., & O’Rahilly, S. (2009) · Diabetologia · doi:10.1007/s00125-009-1545-y · Cited by 19

Atypical Progeroid Syndrome and Partial Lipodystrophy Due to LMNA Gene p.R349W Mutation

Magno, S., Ceccarini, G., Pelosini, C., Ferrari, F., Prodam, F., Gilio, D., Maffei, M., Sessa, M. R., Barison, A., Ciccarone, A., et al. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa108 · Cited by 18

The renal manifestations of type 4 familial partial lipodystrophy: a case report and review of literature

Chen, R., Zhang, L., Ye, W., Wen, Y.-B., Si, N., Li, H., Li, M., Li, X., & Zheng, K. (2018) · BMC Nephrology · doi:10.1186/s12882-018-0913-6 · Cited by 18

JUVENILE DERMATOMYOSITIS

Rider, L. G., Lindsley, C. B., & Cassidy, J. T. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-6581-4.10024-x · Cited by 17

Role of TGF-β signalling in PCOS associated focal segmental glomerulosclerosis

Bhati, M., Prabhu, Y. D., Renu, K., Vellingiri, B., Thiagarajan, P., Panda, A., Chakraborty, R., Myakala, H., & Gopalakrishnan, A. V. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.07.032 · Cited by 18

Histological Manifestations of Diabetic Kidney Disease and its Relationship with Insulin Resistance

Adeva‐Andany, M. M., Adeva-Contreras, L., Fernández‐Fernández, C., Carneiro-Freire, N., & Domínguez-Montero, A. (2022) · Current Diabetes Reviews · doi:10.2174/1573399818666220328145046 · Cited by 19

A new mutation in the CAVIN1/PTRF gene in two siblings with congenital generalized lipodystrophy type 4: case reports and review of the literature

Mancioppi, V., Daffara, T., Romanisio, M., Ceccarini, G., Pelosini, C., Santini, F., Bellone, S., Mellone, S., Baricich, A., Rabbone, I., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1212729 · Cited by 18

Metabolomic Analysis of the Effects of Leptin Replacement Therapy in Patients with Lipodystrophy

Grewal, S., Gubbi, S., Fosam, A. E., Sedmak, C., Sikder, S., Talluru, H., Brown, R. J., & Muniyappa, R. (2019) · Journal of the Endocrine Society · doi:10.1210/jendso/bvz022 · Cited by 15

Urocortin ameliorates diabetic nephropathy in obese db/db mice

Li, X., Hu, J., Zhang, R., Sun, X., Zhang, Q., Guan, X., Chen, J., Zhu, Q., & Li, S. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.155 · Cited by 16

Metreleptin for metabolic disorders associated with generalized or partial lipodystrophy

Simha, V. (2014) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2014.894877 · Cited by 13

Reversal of hypertriglyceridemia in diabetic BTBR ob/ob mice does not prevent nephropathy

Attie, A., Schueler, K., Keller, M. P., Mitok, K. A., Simonett, S. P., Hudkins, K. L., Mehrotra, K., Graham, M. J., Lee, R. G., & Alpers, C. E. (2021) · Laboratory Investigation · doi:10.1038/s41374-021-00592-8 · Cited by 14

Complications of lipodystrophy syndromes

Akıncı, G., Güler, M. Ç., & Akıncı, B. (2021) · La Presse Médicale · doi:10.1016/j.lpm.2021.104085 · Cited by 16

Metreleptin Treatment in Three Patients with Generalized Lipodystrophy

Musso, C., Major, M. L., Andres, E., & Simha, V. (2016) · Clinical Medicine Insights Case Reports · doi:10.4137/ccrep.s40196 · Cited by 13

Congenital generalized lipodystrophy: The evaluation of clinical follow-up findings in a series of five patients with type 1 and two patients with type 4

Güneş, N., Kutlu, T., Tekant, G. T., Eroğlu, A. G., Çomunoğlu, N., Öztürk, B., Önay, H., & Tüysüz, B. (2019) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2019.103819 · Cited by 13

Familial partial lipodystrophy and proteinuric renal disease due to a missense c.1045C > T LMNA mutation

Fountas, A., Giotaki, Z., Dounousi, E. C., Liapis, G., Bargiota, Α., Tsatsoulis, A. A., & Tigas, S. K. (2017) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-17-0049 · Cited by 12

Leptin Therapy in Patients with Lipodystrophy and Syndromic Insulin Resistance

Brown, R. J., & Görden, P. (2014) · Springer eBooks · doi:10.1007/978-3-319-09915-6_18 · Cited by 12

W(h)ither Metreleptin for Lipodystrophy and the Metabolic Syndrome?

Mantzoros, C. S. (2010) · Endocrine Practice · doi:10.4158/ep10038.ed · Cited by 11

Treatment Options for Lipodystrophy in Children

Mainieri, F., Tagi, V. M., & Chiarelli, F. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.879979 · Cited by 10

Lipodystrophy Syndromes

Tsoukas, M. A., & Mantzoros, C. S. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00037-8 · Cited by 10

Inflammatory diseases of the subcutaneous fat

Luzar, B., & Calonje, E. J. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-5649-2.00010-x · Cited by 10

Lipodystrophy Severity Score to Assess Disease Burden in Lipodystrophy

Brown, R. J., Akıncı, B., Yosef, M., Phillips, H., Khalatbari, S. H., Sorkina, E., Santini, F., Vigouroux, C., Brush, M. N., Meral, R., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf103 · Cited by 9

Lipodistrofias primarias: presentación clínica y diagnóstico

Cortés, V., & Santos, J. L. (2019) · Revista médica de Chile · doi:10.4067/s0034-98872019001101449 · Cited by 9

Lovastatin for reduction of leptin in nondialysis patients with type 2 diabetic nephropathy.

Gholamin, S., Razavi, S., Taghavi-Garmestani, S.-M., Ghorbanihaghjo, A., Rashtchizadeh, N., Safa, J., Vatankhah, A. M., Azizi, T., & Argani, H. (2014) · Iranian Journal of Kidney Diseases · Cited by 9

Clinical Guidance for Lipodystrophy Syndromes: From Diagnosis and Work-Up to Treatment

Gilio, D., Foss‐Freitas, M. C., & Oral, E. A. (2025) · Current Diabetes Reports · doi:10.1007/s11892-025-01603-4 · Cited by 13

Metreleptin treatment of non-HIV lipodystrophy syndromes

Chevalier, B., Lemaître, M., Leguier, L., Mapihan, K. L., Douillard, C., Jannin, A., Espiard, S., & Vantyghem, M. (2021) · La Presse Médicale · doi:10.1016/j.lpm.2021.104070 · Cited by 8

Lipodystrophies in non-insulin-dependent children: Treatment options and results from recombinant human leptin therapy

Calcaterra, V., Magenes, V. C., Rossi, V., Fabiano, V., Mameli, C., & Zuccotti, G. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106629 · Cited by 6

Metreleptin in lipodystrophy: a profile of its use

Deeks, E. D. (2019) · Drugs & Therapy Perspectives · doi:10.1007/s40267-019-00622-y · Cited by 6

Lipodystrophie-Erkrankungen

Miehle, K., von Schnurbein, J., Faßhauer, M., Stümvoll, M., Borck, G., & Wabitsch, M. (2017) · Medizinische Genetik · doi:10.1007/s11825-017-0162-2 · Cited by 3

Kinetics of zinc status and zinc deficiency in Berardinelli-Seip syndrome

Santos, M. G. D. N., Baracho, M. D. F. P., Vale, S. H. D. L., Leite, L. D., Rocha, É. D. D. M., de Brito, N. J. N., França, M. C., Almeida, M. D. G., Chiquetti, S. C., Marchini, J. S., et al. (2012) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2011.11.002 · Cited by 5

Nephrotic range proteinuria associated with focal segmental glomerulosclerosis reversed with pioglitazone therapy in a patient with Dunnigan type lipodystrophy

Sharma, A., Bourey, R. E., Edwards, J. C., Brink, D. S., & Albert, S. G. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108620 · Cited by 5

Serum and urinary leptin and ghrelin in children with nephrotic syndrome.

Dinleyici, M., Yıldız, B., Çetin, N., Kural, N., & Alataş, Ö. (2013) · PubMed · Cited by 5

Risk factors for diabetic foot ulcers in metreleptin naïve patients with lipodystrophy

Saydam, O., Saydam, B. Ö., Adıyaman, S. C., Ince, M. S., Eren, M. E., Keskin, F., Bilen, H., Dağdeviren, M., Kaya, S., Akıncı, G., et al. (2021) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-021-00132-9 · Cited by 5

A very rare cause of acute pancreatitis: Berardinelli-Seip congenital lipodystrophy

İşlek, A., Sayar, E., Yılmaz, A., Duman, Ö., & Artan, R. (2014) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2014.3667 · Cited by 4

Lipodystrophy Syndromes

Gao, C., & Mantzoros, C. S. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00038-1 · Cited by 4

Membranous glomerulonephritis with an LMNA mutation

Fujita, K., & Hatta, K. (2018) · CEN Case Reports · doi:10.1007/s13730-018-0303-8 · Cited by 3

Effect of exogenous leptin on serum levels of lipids, glucose, renal and hepatic variables in both genders of obese and streptozotocin-induced diabetic rats.

Hayatdavoudi, P., Ghasemi, M., Zendehbad, B., Soukhtanloo, M., Golshan, A., & Hadjzadeh, M. (2015) · PubMed Central · Cited by 3

Advances of pharmacological therapies in lipodystrophy syndromes: current evidence and future directions

Besci, Ö., Güler, M. Ç., Foss‐Freitas, M. C., & Oral, E. A. (2025) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2025.2574318 · Cited by 2

Congenital generalized lipodystrophy in children: Berardinelli–Seip syndrome – two rare cases with renal manifestations

Rao, G. R., Satya, S., Prathima, K. M., Lavanya, D. S., Sandeep, K., & Amareswar, A. (2016) · Indian Journal of Paediatric Dermatology · doi:10.4103/2319-7250.193008 · Cited by 2

Podocytopathies associated with familial partial lipodystrophy due to LMNA variants: report of two cases

Morguetti, M. J., Neves, P. D. M. D. M., Korkes, I., Padilha, W. S. C., Jorge, L., Watanabe, A., Watanabe, E. H., Malheiros, D. M. A. C., Noronha, I. D. L., Dib, S. A., et al. (2024) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-4292-2023-0204 · Cited by 2

Síndrome de Berardinelli-Seip en diálisis peritoneal

Bande-Fernández, J. J., García-Castro, R., Sánchez-Álvarez, J. E., Rodríguez-Suárez, C., Coronel, D., Hidalgo, C., Istanbuli, B., Bueno, C. M., & del Rio-García, L. (2015) · Nefrología · doi:10.1016/j.nefro.2015.08.002 · Cited by 2

The emerging clinical significance of leptin in humans with absolute or relative leptin deficiency

Moschos, S. J., & Mantzoros, C. S. (2005) · Current Opinion in Internal Medicine · doi:10.1097/01.med.0000177421.80858.74 · Cited by 2

Lipodystrophiesyndrome – klinische Präsentation und Management

Beghini, M., & Scherer, T. (2024) · Journal für Endokrinologie Diabetologie und Stoffwechsel · doi:10.1007/s41969-024-00255-1 · Cited by 1

A new type of familial partial lipodystrophy: distinctive fat distribution and proteinuria

Yürekli, B. Ş., Kutbay, N. Ö., Altay, C., Ünlü, Ş. M., Şen, S., Önay, H., Atık, T., & Akıncı, B. (2018) · Endocrine Research · doi:10.1080/07435800.2018.1470188 · Cited by 1

Clinical Applications of Leptin

Oral, E. A., & DePaoli, A. M. (2006) · Springer eBooks · doi:10.1007/978-0-387-31416-7_17

Severe generalized lipodystrophy as a rare presentation of fibrocalculous pancreatic diabetes - is there a common genetic link?

Shamas, M. N., Ganie, M. A., Ahmed, S., Laway, B. A., Pala, N. A., & Act, A. (2009) · Indian Journal of Endocrinology and Metabolism

Miscellaneous hormones

Dalan, R., & Leow, M. K. (2014) · Side effects of drugs annual · doi:10.1016/b978-0-444-62635-6.00043-7

METRELEPTINA: TRATAMIENTO PARA LAS COMPLICACIONES METABÓLICAS DE LA LIPODISTROFIA GENERALIZADA.

Lima-Martínez, M. M. (2016) · Actualidad Contable FACES

Akromegalie und generalisierte Lipodystrophie

Bock, F. D., Kiwit, U., Hilbert, P., & Horneff, G. (2007) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-007-1494-9

Berardinelli-Seip syndrome in peritoneal dialysis

Bande-Fernández, J. J., García-Castro, R., Sánchez-Álvarez, J. E., Rodríguez-Suárez, C., Coronel, D., Hidalgo, C., Istanbuli, B., Bueno, C. M., & del Rio-García, L. (2015) · Nefrología (English Edition) · doi:10.1016/j.nefroe.2015.11.005

Effects of Metreleptin on Proteinuria in Patients With Lipodystrophy

Lee, H. L., Waldman, M. A., Auh, S., Balow, J. E., Cochran, E. K., Görden, P., & Brown, R. J. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00200 · Cited by 19

Renal complications of lipodystrophy: A closer look at the natural history of kidney disease

Akıncı, B., Ünlü, Ş. M., Çelik, A., Şimşir, İ. Y., Şen, S., Nur, B. G., Keskin, F. E., Saydam, B. Ö., Kutbay, N. Ö., Yürekli, B. Ş., et al. (2018) · Clinical Endocrinology · doi:10.1111/cen.13732 · Cited by 36

SUN-LB032 Severe Insulin Resistance and Nephrotic Range Proteinuria Reversed by Pioglitazone in a Patient With Dunnigan Type Lipodystrophy

Sharma, A., Nadella, S., & Albert, S. G. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-sun-lb032

Renal Disease in Partial Lipodystrophy

Eisinger, A. J., Shortland, J. R., & Moorhead, P. J. (1972) · QJM · doi:10.1093/oxfordjournals.qjmed.a067312 · Cited by 70

The renal manifestations of type 4 familial partial lipodystrophy: a case report and review of literature

Chen, R., Zhang, L., Ye, W., Wen, Y.-B., Si, N., Li, H., Li, M., Li, X., & Zheng, K. (2018) · BMC Nephrology · doi:10.1186/s12882-018-0913-6 · Cited by 18